Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Repeated-slip training: an emerging paradigm for prevention of slip-related falls among older adults.

Pai YC, Bhatt TS.

Phys Ther. 2007 Nov;87(11):1478-91. Epub 2007 Aug 21. Review.

2.

C57BL/6 mice are resistant to tumor promotion by full thickness skin wounding.

DiGiovanni J, Bhatt TS, Walker SE.

Carcinogenesis. 1993 Feb;14(2):319-21.

PMID:
8435875
3.

Induction of epidermal ornithine decarboxylase activity in mouse skin exposed to biogenic silica fibers.

Bhatt TS, Beltran L, Walker SE, DiGiovanni J.

Carcinogenesis. 1992 Apr;13(4):617-20.

PMID:
1315627
4.

Tumours of mesothelial origin in rats following inoculation with biogenic silica fibres.

Bhatt TS, Lang S, Sheppard MN.

Carcinogenesis. 1991 Oct;12(10):1927-31.

PMID:
1657431
5.

Synthesis and biological activity of some further cyclopenta[a]phenanthrenes.

Bhatt TS.

Carcinogenesis. 1988 Sep;9(9):1669-72.

PMID:
3409471
6.

Structure-activity relationships for epidermal ornithine decarboxylase induction and skin tumor promotion by anthrones.

DiGiovanni J, Kruszewski FH, Coombs MM, Bhatt TS, Pezeshk A.

Carcinogenesis. 1988 Aug;9(8):1437-43.

PMID:
3402040
7.

Bay region distortions in cyclopenta[a]phenanthrenes.

Kashino S, Zacharias DE, Peck RM, Glusker JP, Bhatt TS, Coombs MM.

Cancer Res. 1986 Apr;46(4 Pt 1):1817-29.

9.

Comparison of the binding of some carcinogenic and non-carcinogenic cyclopenta[a]phenanthrenes to DNA in vitro and in vivo.

Russell JC, Bhatt TS, Jones JR, Coombs MM.

Carcinogenesis. 1985 Aug;6(8):1223-5.

PMID:
4017191
10.
12.

Mutagenesis in Chinese hamster cells by cyclopenta(a)phenanthrenes activated by a human hepatoma cell line.

Bhatt TS, Coombs M, DiGiovanni J, Diamond L.

Cancer Res. 1983 Mar;43(3):984-96.

13.
15.

Co-carcinogenicity of promoting agents.

Vose CW, Coombs MM, Bhatt TS.

Carcinogenesis. 1981;2(7):687-9.

PMID:
7273348
16.

Microsomal metabolites of the aryl hydrocarbon hydroxylase and tumour inhibitor 7,8-benzoflavone.

Coombs MM, Bhatt TS, Vose CW.

Carcinogenesis. 1981;2(2):135-40. No abstract available.

PMID:
7273297
17.

Mutagenic and carcinogenic metabolites of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one.

Coombs MM, Bhatt TS, Kissonerghis AM, Vose CW.

Cancer Res. 1980 Mar;40(3):882-6.

18.

The carcinogenicity of 15,16-dihydro-11-methyl-cyclopenta[a]phenanthren-17-one.

Coombs MM, Bhatt TS, Young S.

Br J Cancer. 1979 Dec;40(6):914-21.

19.

Lack of initiating activity in mutagens which are not carcinogenic.

Coombs MM, Bhatt TS.

Br J Cancer. 1978 Jul;38(1):148-50. No abstract available.

21.

The relative carcinogenic activities of a series of 5-methylchrysene derivatives.

Coombs MM, Bhatt TS, Hall M, Croft CJ.

Cancer Res. 1974 Jun;34(6):1315-8. No abstract available.

22.

Correlation between carcinogenicity and chemical structure in cyclopenta(a)phenanthrenes.

Coombs MM, Bhatt TS, Croft CJ.

Cancer Res. 1973 Apr;33(4):832-7. No abstract available.

23.

Potentially carcinogenic cyclopenta(a)phenanthrenes. VI. 1,2,3,4-Tetrahydro-17-ketones.

Coombs MM, Bhatt TS.

J Chem Soc Perkin 1. 1973;12:1251-4. No abstract available.

PMID:
4795249

Supplemental Content

Loading ...
Support Center